Gene therapy could be the next breakthrough in preventing and treating Alzheimer’s disease in those at risk.
Researchers at the University of Bristol recently reported that they were able to convert the high-risk Alzheimer’s gene, APOE4, into the lower-risk APOE3 gene in human cells using a special technology which could one day be delivered by a one-off injection.
Alzheimer’s disease is the most common form of dementia, accounting for about 60 per cent of the UK’s one million
To provide well-rounded coverage and a breadth of insight across various events, we rely on contributions from several staff writers, each bringing their own area of expertise to our publication.
